What tumor markers are tested for lung cancer?

Apr 17, 2023 Source: Cainiu Health
Dr. Sun Qifeng
Introduction
Lung cancer tumor markers include carcinoembryonic antigen (CEA), cytokeratin 19 fragment antigen (CYFRA 21-1), and squamous cell carcinoma antigen (SCC). A CEA level above 5.0 ng/mL warrants caution for possible malignant tumors. A CYFRA 21-1 level exceeding 3.3 ng/mL may indicate the presence of lung cancer. A positive result for SCC suggests either lung cancer or recurrence of the disease.

Lung cancer can typically be screened through tumor markers such as carcinoembryonic antigen (CEA), cytokeratin 19 fragment antigen (CYFRA 21-1), and squamous cell carcinoma antigen (SCC-Ag). Detailed analysis is as follows:

1. Carcinoembryonic Antigen (CEA)

This is an acidic glycoprotein exhibiting characteristics of human embryonic antigens, serving as a marker for diseases such as lung and colorectal cancers to help determine whether malignant cellular transformation has occurred. A level greater than 5.0 ng/mL warrants concern for possible malignancy.

2. Cytokeratin 19 Fragment Antigen (CYFRA 21-1)

This is a relatively new tumor marker for detecting lung cancer and holds significant value in diagnosing non-small cell lung cancer. If the serum concentration exceeds 3.3 ng/mL, lung cancer may be present.

3. Squamous Cell Carcinoma Antigen (SCC-Ag)

This antigen primarily exists in squamous epithelial cells. Since the lungs also contain abundant squamous epithelium, SCC-Ag can serve as a tumor marker for lung cancer to assess the presence or recurrence of the disease. A positive test result suggests either active lung cancer or recurrence.

In addition, other markers such as neuron-specific enolase (NSE) may also be tested. Once lung cancer is confirmed through tumor marker testing, it is recommended to promptly initiate standardized treatment under a physician's guidance to control disease progression.


Related Articles

View All